We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Vericel Corp
VCEL
$2.3B
| $96.1K | 0.09% |
1,848
-4,980
| -73% | -$218K |
|
452
Universal Insurance Holdings
UVE
$1.16B
| $96K | 0.09% |
4,724
-1,366
| -22% | -$24.6K |
|
|
ARIS
453
DELISTED
Aris Water Solutions
ARIS
| $95.9K | 0.09% |
6,780
-21,421
| -76% | -$218K |
|
454
Bloomin' Brands
BLMN
$680M
| $95.9K | 0.09% |
3,343
+3,292
| +6,455% | +$89.5K |
|
455
PG&E
PCG
$47.8B
| $95.4K | 0.09% |
+5,695
| New | +$95.5K |
|
456
Argan
AGX
$7.98B
| $94.9K | 0.09% |
+1,877
| New | +$88K |
|
457
Host Hotels & Resorts
HST
$16.8B
| $94.7K | 0.08% |
+4,579
| New | +$92K |
|
458
Nicolet Bankshares
NIC
$3.57B
| $94.7K | 0.08% |
1,101
+543
| +97% | +$43.4K |
|
459
Chemed
CHE
$6.78B
| $94.4K | 0.08% |
147
+18
| +14% | +$10.9K |
|
460
Extreme Networks
EXTR
$3.86B
| $94.3K | 0.08% |
8,173
-72
| -0.9% | -$982 |
|
461
M/I Homes
MHO
$3.83B
| $94.3K | 0.08% |
692
+326
| +89% | +$41.4K |
|
462
Jacobs Solutions
J
$15.9B
| $94.2K | 0.08% |
741
+18
| +2% | +$2.11K |
|
463
Insperity
NSP
$1.85B
| $94.2K | 0.08% |
859
+534
| +164% | +$56.8K |
|
464
Immunovant
IMVT
$8.09B
| $94.1K | 0.08% |
2,912
+2,163
| +289% | +$78.9K |
|
|
SMAR
465
DELISTED
Smartsheet Inc.
SMAR
| $93.6K | 0.08% |
2,432
+821
| +51% | +$35.8K |
|
466
Voyager Therapeutics
VYGR
$187M
| $93.5K | 0.08% |
10,039
-10,684
| -52% | -$90.2K |
|
467
Cardinal Health
CAH
$53.4B
| $93.4K | 0.08% |
+835
| New | +$90.1K |
|
468
AdaptHealth
AHCO
$1.46B
| $93.3K | 0.08% |
8,109
-35,371
| -81% | -$300K |
|
469
Plexus
PLXS
$6.81B
| $92.5K | 0.08% |
976
+351
| +56% | +$33.8K |
|
470
Symbotic
SYM
$5.11B
| $92.5K | 0.08% |
2,055
-3,293
| -62% | -$144K |
|
|
JBIO
471
Jade Biosciences
JBIO
$1.22B
| $92.4K | 0.08% |
89
-86
| -49% | -$65.7K |
|
472
Nucor
NUE
$56.4B
| $92.4K | 0.08% |
467
+144
| +45% | +$26.3K |
|
|
KALV
473
DELISTED
KalVista Pharmaceuticals
KALV
| $92.3K | 0.08% |
+7,784
| New | +$104K |
|
474
Ironwood Pharmaceuticals
IRWD
$611M
| $92.2K | 0.08% |
10,589
+8,874
| +517% | +$108K |
|
|
NXRT
475
NexPoint Residential Trust
NXRT
$665M
| $91.9K | 0.08% |
2,855
-3,233
| -53% | -$100K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.